Stoke Therapeutics (STOK) PT Raised to $56 at Needham & Company Following Fireside Chat
Tweet Send to a Friend
Needham & Company analyst Joseph Stringer raised the price target on Stoke Therapeutics (NASDAQ: STOK) to $56.00 (from $48.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
